Iapoptotic effects of Bcl-2, promoting the release of caspase-9 and caspase-3, causing apoptosis. Thus, egcg successfully inhibits the release of IL-6 in inflammatory cells through acute liver Elinogrel Data Sheet injury and reduces apoptosis and autophagy by decreasing the phosphorylation of STAT3. Abbreviations: egcg, epigallocatechin-3-gallate; cona, concanavalin-a; il-6, interleukin-6.submit your manuscript www.dovepress.comDrug Design, Improvement and Therapy 2016:DovepressDovepressepigallocatechin-3-gallate attenuates apoptosis and autophagy 2. Hudspeth K, Pontarini E, Tentorio P, et al. The function of organic killer cells in autoimmune liver illness: a extensive critique. J Autoimmun. 2013;46:55?5. three. Stein-Streilein J, Sonoda KH, Faunce D, Zhang-Hoover J. Regulation of adaptive immune responses by innate cells expressing NK markers and antigen-transporting macrophages. J Leukoc Biol. 2000;67:488?94. four. Tian Z, Gershwin ME, Zhang C. Regulatory NK cells in autoimmune illness. J Autoimmun. 2012;39:206?15. 5. Wang HX, Liu M, Weng SY, et al. Immune mechanisms of Concanavalin A model of autoimmune hepatitis. Planet J Gastroenterol. 2012;18:119?25. 6. Zhang H, Yang J, Zhu R, et al. Mixture therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis. Drug Des Devel Ther. 2015;9:567?74. 7. Yin Q, Li J, Xia Y, et al. Systematic review and meta-analysis: bezafibrate in individuals with key biliary cirrhosis. Drug Des Devel Ther. 2015; 9:5407?419. eight. Zhang Y, Li S, He L, et al. Mixture therapy of fenofibrate and ursodeoxycholic acid in patients with main biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis. Drug Des Devel Ther. 2015;9:2757?766. 9. Heymann F, Hamesch K, Weiskirchen R, Tacke F. The concanavalin A model of acute hepatitis in mice. Lab Anim. 2015;49:12?0. 10. Tacke F, Luedde T, Trautwein C. Inflammatory pathways in liver homeostasis and liver injury. Clin Rev Allergy Immunol. 2009;36:4?2. 11. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol. 2012;3:56. 12. El Kasmi KC, Anderson AL, Devereaux MW, et al. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology. 2012; 55:1518?528. 13. Nemeth E, Baird AW, O’Farrelly C. Microanatomy with the liver immune technique. Semin Immunopathol. 2009;31:333?43. 14. Thornberry NA, Lazebnik Y. Caspases: enemies inside. Science. 1998; 281:1312?316. 15. Adams JM. Methods of dying: several pathways to apoptosis. Genes Dev. 2003;17:2481?495. 16. Jacotot E, Costantini P, Laboureau E, et al. Mitochondrial membrane permeabilization throughout the apoptotic procedure. Ann N Y Acad Sci. 1999; 887:18?0. 17. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a simple biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239?57. 18. Bantel H, Schulze-Osthoff K. Mechanisms of cell death in acute liver failure. Front Physiol. 2012;3:79. 19. Brenner C, Galluzzi L, Kepp O, Kroemer G. Decoding cell death signals in liver inflammation. J Hepatol. 2013;59:583?94. 20. Czaja AJ. Targeting apoptosis in autoimmune hepatitis. Dig Dis Sci. 2014; 59:2890?904. 21. Nikoletopoulou V, Markaki M, Palikaras K, Tavernarakis N. Crosstalk involving apoptosis, necrosis and autophagy. Biochim Biophys Acta. 2013;1833:3448?459. 22. Wang K. Molecular mechanisms of liver injury: apo.
